We are live on ! Find out more
CRMD icon

CorMedix

190 hedge funds and large institutions have $502M invested in CorMedix in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 91 increasing their positions, 28 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 28

55% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 33

19% more capital invested

Capital invested by funds: $421M → $502M (+$80.7M)

10% more funds holding

Funds holding: 172190 (+18)

4.88% more ownership

Funds ownership: 50.37%55.24% (+4.9%)

5% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $17.7M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
190
Holders Change
+18
Holders Change %
+10.47%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
51
Increased
91
Reduced
28
Closed
33
Calls
$18.6M
Puts
$17.7M
Net Calls
+$879K
Net Calls Change
-$3.75M
Name Holding Trade Value Shares
Change
Change in
Stake
LPL Financial
26
LPL Financial
California
$3.73M +$2.88M +237,896 +287%
HSA
27
Hussman Strategic Advisors
Maryland
$3.66M +$3.05M +252,000 +400%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$3.46M
DSCM
29
Divisadero Street Capital Management
Florida
$3.35M +$2.62M +217,050 +306%
Bank of America
30
Bank of America
North Carolina
$3.31M +$869K +71,905 +34%
PAG
31
Private Advisor Group
New Jersey
$3.18M +$2.33M +193,075 +241%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$3.01M +$578K +47,845 +23%
TI
33
Trexquant Investment
Connecticut
$3M -$5.44M -449,957 -64%
Wellington Management Group
34
Wellington Management Group
Massachusetts
$2.91M +$958K +79,250 +46%
Swedbank
35
Swedbank
Sweden
$2.91M
Ameriprise
36
Ameriprise
Minnesota
$2.75M +$710K +58,688 +33%
Victory Capital Management
37
Victory Capital Management
Texas
$2.74M +$2.85M +235,317 New
Goldman Sachs
38
Goldman Sachs
New York
$2.68M +$414K +34,209 +17%
Assenagon Asset Management
39
Assenagon Asset Management
Luxembourg
$2.61M +$2.71M +224,061 New
Jane Street
40
Jane Street
New York
$2.46M -$898K -74,291 -26%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$2.37M +$1.77M +146,500 +255%
Janus Henderson Group
42
Janus Henderson Group
United Kingdom
$2.31M +$2.07M +171,479 +637%
SPIA
43
Steward Partners Investment Advisory
New York
$2.21M +$294K +24,318 +15%
Squarepoint
44
Squarepoint
New York
$2.2M -$1.23M -101,753 -35%
Balyasny Asset Management
45
Balyasny Asset Management
Illinois
$1.85M +$1.22M +101,150 +175%
CAS
46
Coppell Advisory Solutions
Texas
$1.72M +$1.76M +145,392 New
ACM
47
Aquatic Capital Management
Illinois
$1.72M +$1.79M +148,071 New
BHCM
48
Brevan Howard Capital Management
Jersey
$1.7M +$1.53M +126,785 +643%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.7M +$346K +28,600 +24%
Barclays
50
Barclays
United Kingdom
$1.52M -$181K -14,994 -10%

CRMD Hedge Fund Activity: Q3 2025 in Review

190 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2025, worth a combined $502M — up 19% from $421M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new CRMD positions and 33 closed out — a net gain of 18 holders — while 91 added to existing stakes and 28 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $40.2M. The largest seller was Nuveen, cutting an estimated $9.35M.

  • 190 institutional investors held CorMedix (CRMD) as of Q3 2025, up from 172 in Q2 2025.
  • Funds reported $502M of CorMedix stock for Q3 2025, up 19% quarter-over-quarter.
  • 51 funds opened new CorMedix positions in Q3 2025 and 33 closed out, a net change of +18 holders.
  • The largest CorMedix buyer in Q3 2025 was Deerfield Management, an estimated $40.2M added.
  • The largest CorMedix seller in Q3 2025 was Nuveen, an estimated $9.35M sold.

Based on aggregated 13F filings for Q3 2025.